首页> 外文期刊>Neurology India. >The Benefits and Risks of Statin Therapy in Ischemic Stroke: A Review of the Literature
【24h】

The Benefits and Risks of Statin Therapy in Ischemic Stroke: A Review of the Literature

机译:他汀类药物在缺血性中风的益处和风险:文学综述

获取原文
获取原文并翻译 | 示例
           

摘要

Statins are effective cholesterol-lowering drugs for reducing the risks of mortality and morbidity of cardiovascular diseases. Increasing evidence has shown that statin use is associated with a significant beneficial effect in patients with ischemic stroke. Both pre-stroke and post-stroke statin use has been found to be beneficial in ischemic stroke. Furthermore, good adherence is associated with a better clinical outcome, and statin withdrawal is associated with a poor functional outcome in patients with ischemic stroke. High-intensity statin therapy is advocated for the treatment of ischemic stroke. However, there are concerns regarding the adverse effects associated with statin use in ischemic stroke such as intracranial hemorrhage. In this review, we summarize the beneficial effect of statin use in ischemic stroke and discuss the potential risks associated with statin therapy.
机译:他汀类药物是降低心血管疾病的死亡率和发病率的降低的有效胆固醇的药物。 增加的证据表明,他汀类药物使用与缺血性卒中患者的显着有益效果有关。 已发现前卒中前和卒中后他汀类药物在缺血性卒中中有益。 此外,良好的依从性与更好的临床结果相关,他汀类药物戒断与缺血性卒中患者的功能性差异有关。 提倡高强度汀类药物治疗用于治疗缺血性卒中。 然而,涉及与他汀类药物在缺血性卒中中使用的不利影响,例如颅内出血。 在本综述中,我们总结了他汀类药物在缺血性中风中使用的有益作用,并讨论了与他汀类药物治疗相关的潜在风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号